Drug Repurposing: Challenges and Opportunities
-
Chair(s):
Flora Musuamba,
Co-Chair Modelling and Simulation Working Party, Federal Agency for Medicines and Health Products, Brussels, BelgiumOscar Della Pasqua,
Chair Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom -
Session description:
Drug repurposing and translational pharmacology: Lessons learned from COVID-19
Oscar Della Pasqua
Chair Clinical Pharmacology & Therapeutics, University College London, London, United KingdomDrug repurposing in neurological diseases
Robert Pitceathly
Honorary Consultant at The National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London, United KingdomOral communication speaker - to be confirmed in 2023.
Barriers to bring repurposed medicines to paediatric patients
Francesca Rocchi
Clinical Trial Unit, University Department of Paediatrics, Bambino Gesù Children's Hospital, Rome, ItalyDrug repurposing: regulatory experience and expectations
Dr Flora Musuamba
Federal Agency for Medicines and Health Products, Brussels, Belgium
Speakers
-
Dr Giuseppe PontrelliClinical Trial Unit, University Department of Paediatrics, Bambino Gesù Children's Hospital, Rome, Italy
-
Flora MusuambaFederal Agency for Medicines and Health Products, Brussels, Belgium
-
Oscar Della PasquaChair Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom
-
Robert PitceathlyHonorary Consultant at The National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London, United Kingdom
Leave A Comment